(Q44054578)

29 November 2017

title

The antipsychotic drug sulpiride does not affect bodyweight in male rats. Is insulin resistance involved? (English)

1 reference

29 November 2017

1 reference

1 reference

Trino Baptista

1

1 reference

29 November 2017

Anny Lacruz

2

1 reference

29 November 2017

Ximena Pàez

3

1 reference

29 November 2017

Luis Hernàndez

4

1 reference

29 November 2017

Serge Beaulieu

5

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

European Journal of Pharmacology

29 November 2017

published in

1 reference

29 November 2017

volume

447

1 reference

29 November 2017

issue

1

1 reference

29 November 2017

page(s)

91-98

1 reference

Body weight gain induced by antipsychotic drugs: mechanisms and management

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901816-2

Long term administration of some antipsychotic drugs increases body weight and feeding in rats. Are D2 dopamine receptors involved?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901816-2

Puberty modifies sulpiride effects on body weight in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901816-2

Systemic sulpiride increases dopamine metabolites in the lateral hypothalamus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901816-2

Effects of long-term administration of clozapine on body weight and food intake in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901816-2

Enhancement of amphetamine anorexia after chronic administration of sulpiride in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901816-2

Lithium and body weight gain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901816-2

Tamoxifen prevents sulpiride-induced weight gain in female rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901816-2

Amantadine in the treatment of neuroleptic-induced obesity in rats: behavioral, endocrine and neurochemical correlates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901816-2

Glucose tolerance and serum insulin levels in an animal model of obesity induced by the antipsychotic drug, sulpiride.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901816-2

Mechanism of the neuroleptic-induced obesity in female rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901816-2

Glucose tolerance and serum insulin levels in an animal model of obesity induced by sub-acute or chronic administration of antipsychotic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901816-2

Endocrine and metabolic abnormalities involved in obesity associated with typical antipsychotic drug administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901816-2

Serum leptin levels increase rapidly after initiation of clozapine therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901816-2

Insulin binding and action on adipocytes from female rats with experimentally induced chronic hyperprolactinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901816-2

Insulin resistance: an adaptation for weight maintenance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901816-2

Effect of chlorpromazine on blood glucose and plasma insulin in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901816-2

Peripheral glucose metabolism in human hyperprolactinaemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901816-2

Increased body weight associated with prolactin secreting pituitary adenomas: weight loss with normalization of prolactin levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901816-2

Leptin--much more than a satiety signal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901816-2

Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901816-2

Obesity and insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901816-2

Antipsychotic drug-induced obesity in rats: correlation between leptin, insulin and body weight during sulpiride treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901816-2

Effect of estrogen on hyperprolactinemia-induced glucose intolerance in SHN mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901816-2

Different effects of antipsychotic drugs on insulin release in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901816-2

Hyperprolactinemia stimulates food intake in the female rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901816-2

The effect of neuroleptic drugs on serum testosterone level in the male rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901816-2

Sulpiride injections in the lateral hypothalamus induce feeding and drinking in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901816-2

Mechanism of the body weight increase induced by systemic sulpiride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901816-2

Effects of antipsychotic drugs on cytokine networks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901816-2

Human genomics and obesity: finding appropriate drug targets.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901816-2

Blood glucose and prolactin in hyperprolactinemic rats exposed to restraint and surgical stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901816-2

Neuroanatomical specificity of prolactin-induced hyperphagia in virgin female rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901816-2

Decreased sensitivity to insulin in women with microprolactinomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901816-2

Involvement of sex hormone in body weight gain by selective D2 receptor antagonist sulpiride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901816-2

Atypical antipsychotics and weight gain--a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901816-2

Bodyweight gain with atypical antipsychotics. A comparative review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901816-2

10.1016/S0014-2999(02)01816-2

7 January 2021

Identifiers

DOI

1 reference

29 November 2017

1 reference